In the Media

Connect with Lyme

In the Media


Jacksonville Lyme disease patients say they had to ask a dozen times for a test

There is a history of misdiagnosis and underdiagnosis of tick-borne diseases across the country, but especially in Florida. Dr. Kerry Clark of UNF states that tests are not sensitive enough and cases are getting missed. In addition to testing issues, doctors in Florida don't consider tick-borne disease as a part of their clinical evaluation, leading one woman to a dozen different doctors before figuring out what was wrong with her child. Project Lyme board member Melissa Bell joined ABC News Jacksonville on Wednesday morning to support these claims with her own son's story of misdiagnosis and illness

In the Media


Flightpath Licenses the First Antibiotic that Selectively Kills Lyme Disease Spirochetes

Since 2018, Project Lyme has granted over $1 million to Bay Area Lyme Foundation to support their rigorous scientific agenda. Project Lyme is excited to have contributed to many multi-year research projects which Bay Area Lyme manages. A portion of the money Project Lyme raised at our 2020 Gala was used to fund a recent study with Flightpath Biosciences, Inc. Yesterday, they announced a newly licensed antibiotic that selectively kills Lyme Disease spirochetes. They are developing a narrow-spectrum antimicrobial therapeutic that can kill the bacteria causing Lyme disease without destroying the gut microbiome or contributing to the global Antimicrobial Resistance problem which has been associated with increased risk of chronic diseases.